Ch3rity registration number.. L165956
COST OF CANCER
TRUSTEES. REPORT AND
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
CSW Accountancy Ltd

Cost of Cancer
Contents
P•ge
Trustees, Report
Independent Examiner's Report
Statement of Flnancial Activitles
Statement of Financi31 Position
Notes to the Financial Statements
8-11

Cost of Cancer
Trustees. Report For The Year Ended 31 December 2025
The trustees present their report and the financial Statements for the year ended 31 December 2025.
Obje¢tive$ and Activities
Alm$ and Objective$
The objective of the charlty is the relief or the financial har¢shlp among people suffering from cancer through the provision
ofg￿rnts.
The Trustees are aware of the Charity Commission Guidance on public benefit and therefo￿ look to ensure their activities
and grants provided meet this guidance together with the objectives Set out in the Trust Deed.
During 2025, the charity continued to see significant demand for financial assistance from people undergoing cancer
treatment. The ongoing pressures on household finances. combined with the financial impact that a cancer diagnosis and
treatment can have on individua15 and familie5, rneans that the support provided by C05t of Cancer retnains as important a5
ever.
A key objective carrled forward from the previous year was to increase the amount of financial support belng distrlbuted.
The charity had built up reserves partly as a result of difficulties processing the Increasing number of applications received
and was therefore keen to reduce the walting Ilst and ensure that available funds were being used to support those for
whom the ch3rity was established.
Signlficant progress was made during 2025, wlth both the number of famllies helpe¢ and the value of grants awarde¢
Increasing substant1311y compared with the previous year.
Fundraising nevertheless remains challenging. The charity continues to recognise that changes in people's financial
circumstances and the cost of living have affected both Individual donations and participation In fundraising activities.
Developing relationships with businesses and sponsors therefo￿ remains an irnportant part of the charity's strategyi
alongside encouraging individuals and supporter5 to organise events and fundraising artivities.
The charity a150 continue5 to Use social media to raise awareness of its work, fundraising activities and the support available
to people undergoing cancer treatment.
The monthly lottery continues to provide a regular source of income for the charityi although attracting new rnembers
remalns an ongolng objective.
Public Benefit
The trustees confirm that they have complied with the requirements of Sertion 17 of the Charities Act 2011 to have due
regard to the Charity Commission's guidance on public benefit.
Achievements and Performance
Main Achievements
During 2025, income from donations and gifts was £1,315, with a further £4,287 received through Gift Aid, giving total
donatlons and legacy income of E5,602.
Fundraising event5 generated £14,124 during the year, with 5pon50r5hip5 and Social lotterie5 providing a further £2,662.
Income from other trading activities was therefore E16,786.
Including incorne frotn charitable artivities of £288 investrnent incorne of £1,347, the charity'5 total income for the year
Was £24,023.
Most Importantly, durlng 2025 the charity provlded flnanclal assistance totalling £22,871 to 15 familles affected L>y cancer.
This represents a substantlal Increase in the level of dlrecr charltable support provlded during the year and Is a particularly
positive development ror the charlty. One of the objectives identified in the previous year's Trustee Report was to reduce the
W31ting list and make greater use of the funds that had accumulated in reserves.
.CONTINUED
Page I

Cost of Cancer
Trustees. Report (continued)
For The Year Ended 31 December 2025
Maln A¢hlevement$ - continued
The signlficant Increase in both the number of famllies helped and the value of grants awarded durlng 2025 demonstrates
re31 progress tOW3rds this objective and means that the charlty has been 3ble to provlde me3ningful fin3nci31 assistance to
considerably more people during a very difficult period In their lives.
Demand for support ￿MaInS high, and the Trustees continue to recognise the importance of balancing the need to help as
many families as possible with ensuring that grants are awarded fairly, appropriately and at a level that is sustainable for
the charity.
Cost of Cancer continues to be operated on a voluntary ba515 and does not employ any staff. This enables the charity to
maintain a strong focus on directing its available resources towards its charitable purpose.
Financial Review
Financial Position
Total income for the year was £24,023, compared with £29,668 in 2024.
Total expendlture Increased to £29,219, compared wlth £13,723 In the prevlous year. Thls Increase was prlncipally due to
the substantially greater level of grants awarded to individuals during 2025.
As a ￿SUIt, the charity ocorded a deficit OF E5,196 for the year, compared with a surplus of £15,945 in 2024.
The Trustees regard this use of accumulated funds as consistent with the charity's objettives and the intention expressed in
the p￿ViouS year's report to Increas& grant giving and reduce the level of surplus ￿serVeS. The deficit during the year
therefore principally reflects the charity putting more of Its 3vai13ble funds to work in directly supporting people affected by
Cancer.
At 31 December 2025, the charity held £67,888 in cash at bank and in hand. After Credito￿ of £840, total unrestricted
funds and net assets were £67,048, compared with £72,244 at the end of 2024.
Reserves Policv
The charity's reserves policy is to maintain sufficient reserves to enable it to continue its activities and meet anticipated
comtnitments. Although reserves remain above the level required for normal operating purposes, the Trustees are mindful
or the continuing high demand for financial support and Intend to conrinue using the charlty's resources to increase Its
charitable impact while maintaining an appropriate financial reserve.
FUTURE PLANS
The charity'5 principal al￿ remain5 to 1￿C￿aSe the number of people and fa￿llieS It Is able to 5UPPOrt.
Following the substantial increase in grant5 awarded during 2025, the Tru5tee5 intend to continue working through
applications as efficiently as ptsssible while ensuring that the charity's grant-making process remains fair and sustainable.
Fundraising will remaln essential if thls Increased level of charitable support is to continue. The charity therefore intends to..
continue developing relationships with businesse5 and sponsors,.
encourage more individuals and supporters to organise fundraising activities.
increase awareness of Cost of Cancer through social rnedia and other channels,.
continue promoting the rnonthly lottery and seek to Increase participation,.
organise and 5UPPOrt fundraising events., and
continue ￿lSing awareness of the financial a55iStance available to people underyoing cancer t￿atMent.
The Tru5tee5 will continue to ￿OnItOr the level of reserves alongside the nurnber and value of applicatlOn5 received, with the
aim of ensuring that funds raised a￿ used effectively tt> pmvide meaningful financial assistance to those affected by cancer.
Structure. Governance and Management
Page 2

Cost of Cancer
Trustees. Report (continued}
For The Year Ended 31 December 2025
Goveming Document
Goveming t>o¢ument
The charity is controlled by its goveming document, a Deed of Trust, and constitutes an unincorporated charity.
Key De¢i$ion$
All Trustees are responsible for decision making in olation to the gont-giving process. If any Trustee knows an individual
who opplies for a55i5tsnce, that Trustee must abstain from the decision-making process in order to ensufft that applications
are considered fairly and irnpartially.
Trustee Appolntments
When appointing a new Trustee, the existing Trustees will be consulted. Suitable individuals may then be approached to
assist the charity as Trustees, following which a confirmation meeting will be held with all Trustees.
Reference and Admlnlstratlve Detslls
Trustees
Mrs Nicola Moss
Mrs Emma Thornas
Mrs Catherine Bamard
Charity Number
1165956
Prlnclpal Addre$$
Unit 8 Green Court
Village Farm Industrlal Estate
Pyle
Bridgend
CF33 6BN
Endependent Examiner
Carl West ACA
CSW Accountancy Ltd
ICAEW
43 Brynymor Road
Gowerton
Swansea
SA4 3EY
Page 3

Cost of Cancer
Trustees. Report (continued}
For The Year Ended 31 December 2025
The trustees, report was approved by the board of trustees and signed on its behalf by..
Mrs Nicola Moss
Trustee
0810912026
Page 4

Cost of Cancer
Independent Examiner's Report to the Trustees of Cost of Cancer
For The Year Ended 31 December 2025
I report to the trustees on my examination of the account5 of Cost of Cancer Ithe Trustl for the year ended 31 December
2025.
Responslbllltles and Basls of Report
As the charity trustees or the Trust you are responslble for the preparatlon of the accounts in accordance with the
requirements of the Charities Act 2011 I-the Act").
I report in respect of my examination of the Trust's accounts carried out under section 145 of the 2011 Act and in carrying
out my examination, I have followed the applicable Directions given by the Charity Commission under section 1451Sllbl of
the Act.
Independent Examiner's Statement
I have completed my exarnination. I confirm that no material tnatters have come to rny attention in connection with the
examination giving rne cause to believe that in any rnaterial ￿Spect..
accounting records were not kept in respect of the Trust as required by section 130 of the Act., or
2. the accounts do not accord wlth those ￿cOrdS. or
3. the accounts do not comply with the applicable requirements concerning the form and contents of accounts set out in
the Charities IAccountS 3nd Reports) Regulations 2008 other than any requirement that the accounts give a 'true and
fair view, which Is not 3 matter considered as p3rt of an Independent examination.
I have no concerns and have come across no other marters in connection with the examlnation to whlch attention should be
d￿Wrn In this report In order to enable a proper understanding of the accounts to be reached.
Carl West ACA
0810912026
43 Brynymor Road
Gowerton
Swansea
SA4 3EY
Page 5

Cost of Cancer
Statement of Financial Activities
For The Year Ended 31 December 2025
2025
2024
Unrestrlcted Unrestrlcted
funds
funds
Notes
INCOME AND ENDOWMENTS FROM:
Donations and legacies
Charitable activitles..
5,602
4.389
Charitable activities
Other trading activities
Investments
288
16,786
1,347
34
23,243
2,002
24,023
29,668
EXPENDITURE ON:
Raising funds
Charitable activities..
16,3481
15,7811
Charitable activities
122,8711
17,9421
129,2191
113,7231
NET (EXPENDITURE)IINCOME
15,1961
15,945
NET MOVEMENT IN FUNDS
15,1961
15,945
RECONCILIATION OF FUNDS:
Total funds brought forward
72,244
56,299
TOTAL FUNDS CARRIED FORWARD
12
67,048
72,244
The notes on pages 8 to 11 form part of these financial statements.
Page 6

Cost of Cancer
Statement of Financial Position
As At 31 December 2025
2025
2024
Unrestrlcted
funds
Total
funds
Notes
CURRENT ASSETS
Debtors
io
300
Cash at bank and in hand
67,888
73,085
67,888
73,385
Creditors: Amounts Falling Due Within One Year
18401
11.1411
NET CURRENT ASSETS (LIABILITIES)
67,048
72,244
TOTAL A$S￿s LESS CURRENT LIABILITIES
67,048
72,244
NET ASSETS
67,048
72,244
FUNDS OF THE CHARITY
Unrestricted Funds
67.048
72.244
TOTAL FUNDS
12
67,048
72.244
On behalf of the board
Mrs Nicola Moss
Trustee
0810912026
The notes on pages 8 to 11 form part of these financial statements.
Page 7

Cost of Cancer
Notes to the Financial Statements
For The Year Ended 31 December 2025
l. General Information
C05t of Cancer is an unincorporated charity r￿Iste￿d with the Charity Comrnission, registered charity number 1165956. The
principal address is Unit 8 Green Court, Village Farm Industrial Estate, Pyle, Bridgend, CF33 6BN.
Accounting Policies
2. 1. Basis of Prepar•tion of Firtancial St•tements
The financial statements have been prepared in accordance with the Charities SORP IFRS 1021 "Accounting and
Reporting by Charifies.. Statement OF Recommended Practice applitable to tharities preparing their atcounts in
accordance with the Financial Reporting Standard applicabl& in the UK and Republic of Ireland IFRS 1021 (effective I
january 20191. Financi31 Reporting Standard 102 "The Financi31 Reporting Standard applicable In the UK and Republic
of Ireland and the Charitie5 Act 2011.
The charity is a Public Benefit Entity as defined by FRS 102.
2.2. Incoming Resources
All incorning ￿SOurceS are included in the statement of financial activities when entitlement has passed to the charity,.
it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be
reliably measured. The following specific policies are applied to particular categories of income..
• income from donations or grants Is recognlsed when there is evidence of eniitlement to the glft, receipt is probable
and Its amount can be measured rellably.
legacy Income Is recognised when receipt Is probable and entitlement is established.
Income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably,
in which case the value is derived from the cost to the donor or the estirnated resale value. Donated facilities and
services are recognised in the accounts when received if the value can be reliably measured. No amounts are included
for the
contrlbution of general volunteers.
Income from contracts for the supply of services is recognised with the delivery of the cont￿Cted service. This is
classified as unrestricted funds unless there is a contractual wuirement for it to be spent on a particular purpose and
returned if unspent, in which case it may be r￿arded as restricted.
2.3. Resources Expended
Expenditure is recognised on an accruals ba515 as a liability is incurred.
Expenditure includes any VAT which cannot be fully recovered, is cla55ified under heading5 of the statement of
financial activitie5 to which it ￿lateS..
expenditure on raising funds Includes the costs of all fUnd￿lSIng actlvlties, events, non charitable trading activitles,
and the sale of donated goods.
expenditure on charitable activities includes all costs Incurred by a charity in undertaking activities that further Its
charitable aims for the benefit of it5 beneficiaries, including those support costs and costs relating to the governance of
the charity apportioned to charitable activities.
• other expenditure includes all expendlture that Is nelther related to raising funds for the charlty nor part of its
expendlture on charitable activitles.
All costs are allocated to expenditure categories reflecting the use OF the resource. Direct costs attributable to a single
activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on
a reasonable. justifiable and consistent basis.
2.4. Cash and Cash Equlvalents
Cash and cash equivalents are basic financial assets and include cash In hand and deposits held at call with banks,
other short-terrn highly liquid Investments that mature in no more than three rnonths frorn the date of acquisition and
are readily convertible to a known arnount of cash with insignificant risk of change in value. and bank overdrafts.
3. Income from Donations and Legacies
2025
2024
Unrestricted Unre$trirte
funds
funds
Oonation5 and gifts
Gift aid
1,315
4.287
1,635
2,754
5,602
4,389
Page 8

Cost of Cancer
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
4. Income from Other Trading Activitie5
2025
2024
Unrestrlcted Unrestrlcted
funds
funds
FUnd￿lsIng events
Sponsorships 150cial lotteries
14,124
2,662
20,559
2,684
16,786
23.243
Investment Income
2025
2024
Unrestricted Unrestrirted
funds
funds
Bank interest receivable
1.347
2.002
Analysls of Expendlture
2025
Artivities
undertaken
dlrectly
Grant
funding of
actlvltle$
Support
costs
(see note 71
Totsl
Raising funds
Charitable activities
5.500
848
6.348
22.871
22,871
5,500
22,871
848
29,219
2024
Activities
undertaken
directly
Grant
funding of
activities
Support
costs
(see note 71
Total
Raising funds
Charitable activitles
4,460
1,321
5,781
7,942
7,942
4,460
7,942
1,321
13,723
Page 9

Cost of Cancer
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
7. Support Costs
2025
Ralslng
funds
Interest payable
Governance costs
840
848
2024
Raising
fund$
Interest payable
Governance costs
1,320
1,321
8. Independent Examiner's Remuneration
2025
2024
Independent examination of the financial statements
840
1,320
9. Average Number of Employee$
Average number of ernployees during the year was.. NIL12024'. 1
10. Debtors
2025
2024
Due within one year
other debtors
300
11. Credltors: Amounts Falllng Due Wlthln One Year
2025
2024
Trade creditors
Accrua15 deferred income
840
1,140
840
1.141
Page 10

Cost of Cancer
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
12. Movement in Funds
Asati
January
Asat31
December
2025
Income
Expenditure
2025
Unrestricted funds
General..
Gener31 unrestricted fund
72,244
24,023
129.2191
67,048
Totsl funds
72,244
24,023
129,2191
67.048
A$atl
J•nu•ry
2024
A$at31
December
2024
Income
Expendlture
Unrestricted funds
General..
General unrestricted fund
56,299
29,668
113,7231
72,244
Total funds
56,299
29,668
113.7231
72,244
13. Tran$artion$ with Tru$tee$
During the year the expenses reirnbur5ed to the trustees or paid directly to third parties were as follows..
2025
2024
14. Related Party Disclosures
Page 11